Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

This Block Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Monday

Author: Avi Kapoor | May 05, 2025 08:11am

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.

  • Keefe, Bruyette & Woods analyst Bose George downgraded the rating for Enact Holdings, Inc. (NASDAQ:ACT) from Outperform to Market Perform and maintained the price target of $39. Enact Holdings shares closed at $37.32 on Friday. See how other analysts view this stock.
  • D. Boral Capital analyst Jason Kolbert downgraded Plus Therapeutics, Inc. (NASDAQ:PSTV) from Buy to Hold. Plus Therapeutics shares closed at $0.6479 on Friday. See how other analysts view this stock.
  • Jefferies analyst Sheila Kahyaoglu downgraded the rating for Parsons Corporation (NYSE:PSN) from Buy to Hold and cut the price target from $75 to $65. Parsons shares closed at $62.81 on Friday. See how other analysts view this stock.
  • Cantor Fitzgerald analyst Matthew Prisco downgraded Onto Innovation Inc. (NYSE:ONTO) from Overweight to Neutral and lowered the price target from $250 to $135. Onto Innovation shares closed at $127.10 on Friday. See how other analysts view this stock.
  • Macquarie analyst Paul Golding downgraded the rating for Block, Inc. (NYSE:XYZ) from Outperform to Neutral and lowered the price target from $110 to $50. Block shares closed at $46.53 on Friday. See how other analysts view this stock.

Considering buying XYZ stock? Here’s what analysts think:

Read This Next:

Photo via Shutterstock

Posted In: ACT ONTO PSN PSTV XYZ

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist